Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2000
06/14/2000EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
06/14/2000EP1007657A2 Hiv-specific oligonucleotides and methods of their use
06/14/2000EP1007655A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
06/14/2000EP1007640A1 New spumavirus isolated from humans
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007551A2 Vaccine against hpv
06/14/2000EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION
06/14/2000EP1007546A1 Molecular mimetics of meningococcal b epitopes
06/14/2000EP1007545A2 Cyclopeptide derivatives as adhesion inhibitors
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007528A2 Robustaflavone, intermediates and analogues and method for preparation thereof
06/14/2000EP1007527A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
06/14/2000EP1007525A1 Aminometyl oxooxazolidinyl benzene derivatives
06/14/2000EP1007518A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
06/14/2000EP1007098A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
06/14/2000EP1007088A1 Recombinant porcine adenovirus vector
06/14/2000EP1007086A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
06/14/2000EP1007083A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
06/14/2000EP1007079A1 Identification of broadly reactive dr restricted epitopes
06/14/2000EP1007077A1 Compounds and their combinations for the treatment of influenza infection
06/14/2000EP1007069A1 Novel coding sequences
06/14/2000EP1007068A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
06/14/2000EP1007062A1 Therapeutic use of hemoglobin to treat head injury
06/14/2000EP1007059A1 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
06/14/2000EP1007058A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS IN COMBINATION THERAPY FOR TREATING HEPATITIS VIRUS INFECTIONS
06/14/2000EP1007057A1 Method of treating herpes infections
06/14/2000EP1007055A1 Methods for the administration of amifostine
06/14/2000EP1007032A1 4-cyano-4-deformylsordaricin derivatives
06/14/2000EP1007031A1 4-cyano-4-deformylsordarin derivatives
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP1007013A1 Parenteral pimaricin as treatment of systemic infections
06/14/2000EP1007006A1 Cefadroxil monohydrate tablet formulation
06/14/2000EP1006796A1 Compositions and methods for administering borrelia dna
06/14/2000EP1006785A1 Antimicrobial proteins
06/14/2000EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
06/14/2000EP0871606B1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
06/14/2000EP0754193B1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
06/14/2000EP0525057B1 Antimicrobial quinolonyl lactams
06/14/2000CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
06/14/2000CN1256631A Methods and composition for treating fungal infections in mannals
06/14/2000CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line
06/14/2000CN1256151A Preparation of multiepitope epitope vaccine
06/14/2000CN1256150A Preparation of epitope vaccine with single monoepitope or multiple monoepitope duplication
06/14/2000CN1256149A Preparation of dissociation-resisting epitope vaccine
06/14/2000CN1256135A Tuberculosis treating medicine and its compounding process
06/14/2000CN1053344C Chinese drug pill for treatment of cold
06/14/2000CN1053343C Chinese tablet for treatment of tuberculosis of lung
06/14/2000CN1053338C Cantharidate antiviral pharmaceutical and its prep.
06/13/2000US6075133 Increased acid stability and enhanced bactericidal activity
06/13/2000US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection
06/13/2000US6075050 Condensation polymers of an aldehyde and aromatic sulfonic acids and fractions thereof, such as formaldehyde naphthalenesulfonic acid condensation polymers
06/13/2000US6075026 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
06/13/2000US6075024 Methods for treating infection using optically pure (S)-lomefloxacin
06/13/2000US6075014 Inhibitors of β-lactamases and uses therefor
06/13/2000US6075011 6-O-substituted erythromycin compounds and method for making same
06/13/2000US6075001 Activation of peroxy bleach
06/13/2000US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein
06/13/2000US6074846 Hepatitis C virus asialoglycoproteins
06/13/2000US6074657 Administration of an injectable antibiotic in the ear of an animal
06/13/2000US6074651 Vaccine based on TGEV for protection of canines against canine coronavirus
06/13/2000US6074649 Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
06/13/2000US6074646 Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
06/13/2000US6074645 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
06/13/2000US6074644 Cytotoxic activity
06/13/2000US6074641 Administering monoclonal antibody
06/13/2000US6074636 Method of using cell surface receptor targeted molecules for the treatment of viral diseases
06/13/2000US6074635 T cell activation
06/13/2000US6073627 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions
06/13/2000CA2206164C Viscous liquid conditioning topical germicides
06/13/2000CA2157196C Inhibitors of herpes viral ribonucleotide reductase
06/13/2000CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
06/13/2000CA2036398C Hiv protease inhibiting agents
06/09/2000CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines
06/08/2000WO2000032825A2 Development of anti-microbial agents based on bacteriophage genomics
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032786A1 gp120 MUTANTS AND BIOLOGICAL APPLICATIONS
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032755A1 Stable, attenuated rabies virus mutants and live vaccines thereof
06/08/2000WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032616A1 Hygromycin a derivatives as antibacterial agents
06/08/2000WO2000032607A1 Crystalline salts of a carbapenem antibiotic
06/08/2000WO2000032606A1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM
06/08/2000WO2000032605A1 Bi-pyrrolidinylvinl (carba) cephalosporins
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032599A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032520A1 Method for activating water and use of activated water of this type
06/08/2000WO2000032234A1 Topical compositions comprising ascomycins
06/08/2000WO2000032228A2 Peptide-based vaccine for influenza
06/08/2000WO2000032227A2 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000WO2000032226A2 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof
06/08/2000WO2000032219A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032213A1 ηδT CELL IMMUNOACTIVITY POTENTIATORS CONTAINING SHIITAKE MUSHROOM HYPHA EXTRACT
1 ... 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 ... 1798